- Antineoplastic Agents, Alkylating Guvenligidrug_safety · draft
- Antineoplastic Agents, Hormonal Guvenligidrug_safety · draft
- Antineoplastic Agents, Immunological Guvenligidrug_safety · draft
- Antineoplastic Agents, Phytogenic Guvenligidrug_safety · draft
- Antioxidants Guvenligidrug_safety · draft
- Antipain Guvenligidrug_safety · draft
- Antiparasitic Agents Guvenligidrug_safety · draft
- Antiparkinson Agents Guvenligidrug_safety · draft
- Antiperspirants Guvenligidrug_safety · draft
- Antiplatyhelmintic Agents Guvenligidrug_safety · draft
- Antiporters Guvenligidrug_safety · draft
- Antiprotozoal Agents Guvenligidrug_safety · draft
- Antipruritics Guvenligidrug_safety · draft
- Antipsikotik Güvenliğidrug_safety · draft
- Antipsychotic Agents Guvenligidrug_safety · draft
- Antipyretics Guvenligidrug_safety · draft
- Antipyrine Guvenligidrug_safety · draft
- Antirheumatic Agents Guvenligidrug_safety · draft
- Antisense Elements (Genetics) Guvenligidrug_safety · draft
- Antisickling Agents Guvenligidrug_safety · draft
- Antispermatogenic Agents Guvenligidrug_safety · draft
- Antistatic Agents Guvenligidrug_safety · draft
- Antistreptolysin Guvenligidrug_safety · draft
- Antithrombin III Guvenligidrug_safety · draft
- Antithrombin Proteinleri Guvenligidrug_safety · draft
- Antithrombins Guvenligidrug_safety · draft
- Antithyroid Agents Guvenligidrug_safety · draft
- Antitiroid İlaç Güvenliğidrug_safety · draft
- Antitoxins Guvenligidrug_safety · draft
- Antitreponemal Agents Guvenligidrug_safety · draft
- Antitrichomonal Agents Guvenligidrug_safety · draft
- Antitrombosit Güvenliğidrug_safety · draft
- Antitubercular Agents Guvenligidrug_safety · draft
- Antitüberküloz İlaç Güvenliğidrug_safety · draft
- Antitussive Agents Guvenligidrug_safety · draft
- Antivenins Guvenligidrug_safety · draft
- Antiviral Agents Guvenligidrug_safety · draft
- Antiviral Güvenliğidrug_safety · draft
- Antiviral Güvenliği: Ayırıcı Tanı Notudrug_safety · draft
- Antiviral Güvenliği: Birinci Basamakdrug_safety · draft
- Antiviral Güvenliği: Güvenli Okumadrug_safety · draft
- Antiviral Güvenliği: Hasta Okuryazarlığıdrug_safety · draft
- Antiviral Güvenliği: Hasta Sorularıdrug_safety · draft
- Antiviral Güvenliği: Klinik Belirsizlikdrug_safety · draft
- Antiviral Güvenliği: Komorbidite Bağlamıdrug_safety · draft
- Antiviral Güvenliği: Kontrol Görüşmesi Hazırlığıdrug_safety · draft
- Antiviral Güvenliği: Kronik Hastalık Bağlamıdrug_safety · draft
- Antiviral Güvenliği: Risk İletişimidrug_safety · draft
- Antiviral Güvenliği: Yaşlı Erişkindrug_safety · draft
- Antiviral Restriction Factors Guvenligidrug_safety · draft
- Apamin Guvenligidrug_safety · draft
- Apatites Guvenligidrug_safety · draft
- Apazone Guvenligidrug_safety · draft
- Apc1 Subunit, Anaphase-Promoting Complex-Cyclosome Guvenligidrug_safety · draft
- Apc10 Subunit, Anaphase-Promoting Complex-Cyclosome Guvenligidrug_safety · draft
- Apc11 Subunit, Anaphase-Promoting Complex-Cyclosome Guvenligidrug_safety · draft
- Apc2 Subunit, Anaphase-Promoting Complex-Cyclosome Guvenligidrug_safety · draft
- Apc3 Subunit, Anaphase-Promoting Complex-Cyclosome Guvenligidrug_safety · draft
- Apc4 Subunit, Anaphase-Promoting Complex-Cyclosome Guvenligidrug_safety · draft
- Apc5 Subunit, Anaphase-Promoting Complex-Cyclosome Guvenligidrug_safety · draft